This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.3346/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36735810
rdf:type
wikibase:Item
schema:description
article scientific artykuł naukowy tieteellinen artikkeli articol științific 2016年论文 artigo científico naučni članak บทความทางวิทยาศาสตร์ vědecký článek scienca artikolo επιστημονικό άρθρο videnskabelig artikel tudományos cikk bài báo khoa học bilimsel makale 2016年论文 artikulong pang-agham научна статия vedecký článok scientific article published on 22 February 2016 teaduslik artikkel wetenschappelijk artikel مقالة علمية نشرت في 22 فبراير 2016 2016年论文 2016年論文 научни чланак vitenskapelig artikkel 2016年論文 artikel ilmiah artículu científicu espublizáu en 2016 artigo científico наукова стаття, опублікована в лютому 2016 2016年论文 vitskapeleg artikkel מאמר מדעי 2016年论文 vetenskaplig artikel artikull shkencor artigo científico ২২ ফেব্রুয়ারি ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак article scientifique scientific article published on 22 February 2016 articolo scientifico 2016년 논문 2016年論文 2016 nî lūn-bûn სამეცნიერო სტატია 2016年論文 научная статья 2016年の論文 article científic мақолаи илмӣ scientific article published on 22 February 2016 wissenschaftlicher Artikel 2016年论文 artículo científico publicado en 2016 2016年論文
p:P577
wds:Q36735810-27CCC427-2CC1-417A-B826-18A30E9AB9CC
wdt:P577
2016-02-22T00:00:00Z
p:P2860
wds:Q36735810-0A78E18A-B714-4415-ACC5-CCED95EBC605 wds:Q36735810-210EEC11-38A6-407B-943F-2E732868D53B wds:Q36735810-292F15F3-4052-45F1-9E62-A26C63AA7FF6 wds:Q36735810-0D2ECF0A-0279-4F6F-9F32-601BC5B302F9 wds:Q36735810-10B38305-25BF-4F18-A2FB-94E23F82DBE7 wds:Q36735810-1D43AD05-08A3-4C18-ACA4-1148C3A22CA0 wds:Q36735810-40DBA7C6-BDFD-42C1-A351-AA370E39E8BF wds:Q36735810-4911AE24-6383-4677-94A7-95C61E407B74 wds:Q36735810-4D56662F-2F77-4716-8437-6885B12118C0 wds:Q36735810-3190A54F-C2C4-4B28-BB0E-74764935DBEE wds:Q36735810-33741E63-691D-4A73-A277-91188D4C7C41 wds:Q36735810-3C1C3389-D72D-4993-BB7F-98522503E948 wds:Q36735810-5A4BF885-EB2E-4465-AB5F-4071552D29CF wds:Q36735810-5F0FC364-FB91-42EE-A896-7AEE0E54C793 wds:Q36735810-5F4DC002-F177-47BE-854F-702CDD1027EF wds:Q36735810-68763038-AE40-4BA6-A339-A89B555A555D wds:Q36735810-563FB6E8-0F8F-4F89-8E20-DCAD74D688E3 wds:Q36735810-7E7B8B04-3F1C-49B0-85BF-427707FC91C1 wds:Q36735810-8C020E79-75A1-4B21-B5B5-A02962C988A9 wds:Q36735810-69E590FC-517C-4149-BC02-818179A81735 wds:Q36735810-6C2A8556-94DC-4263-9CB3-A16DB160F31A wds:Q36735810-75888EF9-4E73-45F0-A58B-F91B4BA27B0E wds:Q36735810-77085C30-0C20-4BCA-B5E4-9D4BC8F6762B wds:Q36735810-A322C220-C76C-4160-A937-42F65B205190 wds:Q36735810-ABFD5A3E-D613-4AE7-834C-DEF99A7C199E wds:Q36735810-AE0612A1-B846-4D2E-AD76-04A140F7724C wds:Q36735810-92BCEF84-BA97-4F22-A525-B745BEF13357 wds:Q36735810-97812F64-ABF8-44A4-8681-F1C7D93FFF5C wds:Q36735810-9E73B2F6-2664-45F2-B2E1-C4B514A052E3 wds:Q36735810-9EEC01A5-8549-4702-A971-330686E5DF1E wds:Q36735810-C1C5782D-3DC0-4B0D-A408-A769AAD07C4D wds:Q36735810-CBFA4DEA-D94B-4686-B55E-A2BB43EB0D1D wds:Q36735810-EDC45575-F1BB-42F8-A330-A85821802A13 wds:Q36735810-E344C781-2AE0-4C16-AD86-BE3B86C74D24 wds:Q36735810-E5BA538A-2AE1-4158-AA22-BCB2278C71EA
wdt:P2860
wd:Q33958214 wd:Q72099684 wd:Q35559273 wd:Q40639156 wd:Q38005208 wd:Q30433139 wd:Q34549410 wd:Q28261854 wd:Q34083625 wd:Q40387387 wd:Q35439366 wd:Q55061788 wd:Q33362698 wd:Q34316960 wd:Q71025400 wd:Q33316357 wd:Q69561570 wd:Q34355826 wd:Q43472495 wd:Q34798105 wd:Q28252396 wd:Q53563131 wd:Q71294754 wd:Q38192228 wd:Q46549268 wd:Q53093363 wd:Q54518670 wd:Q34815786 wd:Q26830893 wd:Q37877450 wd:Q42277364 wd:Q46423653 wd:Q59167181 wd:Q36524353 wd:Q43087338
p:P2093
wds:Q36735810-8678E8EA-3A8F-4E69-A534-0DA69C6B6E3A wds:Q36735810-164CADEC-0DB0-414B-ACBD-E16D7C391D60
wdt:P2093
Yundeok Kim Soo-Jeong Kim
rdfs:label
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
skos:prefLabel
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
schema:name
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
p:P50
wds:Q36735810-58B40508-D09E-4FEA-B017-9D06CFBE00E9 wds:Q36735810-3F866478-8320-46B5-8041-E34E0203CEE8 wds:Q36735810-2AD98409-F4D2-4A4A-A1BB-CA7B4188ECCC wds:Q36735810-000172E5-F292-41FD-B849-219FC446CF04 wds:Q36735810-ED518957-CFFC-4FE2-B606-883E463020B2 wds:Q36735810-BE63C251-7321-4DCE-94EF-5CF8C38B1BBA wds:Q36735810-C556E828-7272-43CE-9DBF-07C2FEB8F5DD wds:Q36735810-D001C8BA-2E5E-46DE-83A5-DDAD6DC574A4 wds:Q36735810-A277BB27-23C8-46FF-96B5-C5F0D65517B4
wdt:P50
wd:Q63498669 wd:Q82420756 wd:Q41274120 wd:Q59691564 wd:Q56191829 wd:Q89132641 wd:Q59591071 wd:Q89132644 wd:Q60679148
p:P1476
wds:Q36735810-541F6F11-735F-49F2-AA17-7BF9F2B5F504
wdt:P1476
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
p:P304
wds:Q36735810-4EFDEF56-1C7F-44AD-9782-F420E6BB709B
wdt:P304
510-518
p:P31
wds:Q36735810-AEB2BF0F-5984-419E-AB61-281F2D4101A2
wdt:P31
wd:Q13442814
p:P921
wds:Q36735810-2C33BE50-725E-42DE-9283-01A09D43A65D
wdt:P921
wd:Q485831
p:P698
wds:Q36735810-FA4223D1-1D10-469A-94C7-23F543E3135B
wdtn:P698
n11:27051233
wdt:P698
27051233
p:P1433
wds:Q36735810-D783C827-B98F-4D53-B6D2-21EF54A89385
wdt:P1433
wd:Q24039955
p:P433
wds:Q36735810-D133771F-7961-4969-9F5E-5B87441A3BA7
p:P478
wds:Q36735810-C10E7885-66E5-4DF7-BA5C-C2D39AC9DA19
wdt:P433
4
wdt:P478
31
p:P356
wds:Q36735810-BBF497A0-F972-4327-B150-75AD3904C8F3
wdtn:P356
n12:JKMS.2016.31.4.510
wdt:P356
10.3346/JKMS.2016.31.4.510
p:P932
wds:Q36735810-9082597D-FF0C-4E39-984A-B9BD02D95376
wdt:P932
4810332